ACTON, Mass. --(BUSINESS WIRE)--May 16, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 2019 UBS Global
Commenced Pod Production at U.S. Manufacturing Facility and Initiated Full U.S. Commercial Launch of Omnipod DASH ™ ACTON, Mass. --(BUSINESS WIRE)--May 2, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ®
Over $200 Million Investment in Massachusetts Creates Hundreds of Local Manufacturing Jobs and a Launchpad for New Product Innovation ACTON, Mass. --(BUSINESS WIRE)--May 2, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod
ACTON, Mass. --(BUSINESS WIRE)--Apr. 4, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the first quarter of 2019 on
ACTON, Mass. --(BUSINESS WIRE)--Feb. 25, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for the three months and full year
ACTON, Mass. --(BUSINESS WIRE)--Feb. 19, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences: The Raymond James
ACTON, Mass. --(BUSINESS WIRE)--Jan. 28, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Corinne Nevinny has been appointed to the Company’s
ACTON, Mass. --(BUSINESS WIRE)--Jan. 25, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full
ACTON, Mass. --(BUSINESS WIRE)--Jan. 7, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Wayde McMillan has been appointed Executive Vice
ACTON, Mass. --(BUSINESS WIRE)--Dec. 18, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 37th Annual J.P.
The Only Insulin Pump to Receive Both ISO 27001 and DTSec Certifications BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 20, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today
BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 19, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 30th Annual
Incorporates Best-In-Class Cyber-Security Protocols and Mobile App Controlled Omnipod BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 7, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod
Highlights Include Beyond Type Run Team NYC Marathon Sponsorship, NASDAQ Closing Bell Ceremony and Global Fundraising Events BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 5, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ®
Achieved Both Positive Operating and Net Income for the First Time in Insulet's History BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 1, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System